CHICAGO -- Omitting lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy did not compromise ...

Please provide your email address to receive an email when new articles are posted on . Extended lymphadenectomy did not improve outcomes in localized muscle-invasive bladder cancer vs. standard ...

March 11, 2010 —Systematic removal of pelvic as well as para-aortic lymph nodes may improve survival time vs pelvic lymphadenectomy alone in patients at medium to high risk for endometrial cancer ...

To evaluate the therapeutic benefit of lymphadenectomy and adjuvant therapy, in particular chemotherapy, we retrospectively analysed survival rates and patterns of recurrence of endometrioid ...

The role of lymphadenectomy has been studied in both the localized and advanced settings over the past few decades, with a strong suggestion of no therapeutic benefit for patients with cT1-2N0M0 and ...

Fluorescence-guided lymphadenectomy after neoadjuvant chemotherapy was linked to improved survival in gastric cancer. It was also significantly associated with more retrieved lymph nodes. The 3-year ...

Patients with histologically proven epithelial ovarian carcinoma, macroscopically confined to the pelvis and optimally debulked (residual tumour ⩽1 cm) were eligible for the study. Further eligibility ...

Removing lymph nodes that appear unaffected by ovarian cancer won’t help and might hurt. If advanced ovarian cancer has not visibly spread to a patient’s lymph nodes, removing the nodes is not only ...

Extensive lymph node removal during surgery for esophageal cancer might not necessarily improve survival, according to new findings. In a study of 606 patients, the extent of lymphadenectomy was not ...